Spravato (esketamine) therapy offers rapid relief for treatment-resistant depression by targeting brain receptors traditional meds miss. Aspire TMS Clinic provides
December 3, 2025
No Comments
Blog & News
- Home
- healthcare-news
Non-invasive therapies like TMS and Spravato offer effective, FDA-approved alternatives for treatment-resistant depression, providing fast relief with fewer side effects
December 2, 2025
No Comments
Treatment-resistant depression resists traditional treatments. Spravato (esketamine) at Aspire TMS Clinic offers a rapid, FDA-approved nasal spray therapy, providing new
November 30, 2025
No Comments
Spravato, an FDA-approved esketamine nasal spray, offers new hope for treatment-resistant depression, with Aspire TMS Clinic providing personalized, comprehensive care
November 13, 2025
No Comments
